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by Dual X-ray, Axial Dual-energy Photon X-ray 
Absorptiometry and Laser Absorptiometry of 
Calcaneus 
 
 
 
Abstract 
The objective of this study was to validate the use of bone 
mineral measurements of the calcaneus bone by dual X-ray 
and laser (DXL) in a cross-sectional study carried out in an 
osteoporosis clinic. Measurements of bone mineral density 
(BMD) at proximal femur and spine were obtained by dual-
energy photon X-ray absorptiometry (DEXA). Osteoporosis 
was defined by a DEXA T-score <-2.5 at the femoral neck or 
lumbar spine. Sensitivity, specificity and kappa statistics for 
DXL were calculated, assuming the DEXA measurement as 
the gold-standard.  The study included 475 women with a 
mean age of 54±11.9 years. 15% had osteoporosis while 39% 
were osteopenic (-2.5<T-score between<-1) at the femoral 
neck or spine. A significant correlation (p<0.001) was found 
between BMD values as measured by DXL at femoral neck 
and DEXA at the lumbar spine. Assuming the same T-score 
cut-off value for the diagnosis osteoporosis and a modified 
cut-off value for the diagnosis of osteopenia (-2.5<T-score<-
1.5), yields a sensitivity of 83% and a specificity of 74% to 
86% for the DXL device. In conclusion, BMD measured at 
the calcaneal bone by DXL, has a good correlation with that 
measured by axial DEXA. 
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Introduction 
Low bone mineral density (BMD) is an important risk 
factor for osteoporosis. About 80% of the variability in 
bone strength depends on the bone mineral content.1 
The lifetime prevalence for osteoporosis is more than 30% for 
women and 13% for men. The definition of osteoporosis is 
centered on the level of bone mass, measured as BMD.  Os-
teoporosis denotes a value for BMD or bone mineral content 
that is 2.5 standard deviations (SD) or more below the young 
adult mean value (T-score <-2.5). Osteopenia means a T-
score that lies between -1 and -2.5. It is well-documented that 
measurements of BMD in the heel bone can be used for pre-
diction of fracture risk.2-5The World Health Organization 
(WHO) guidelines issued in 1994 is used to combat this dis-
ease and its severe consequences.6 Lack of access to diag-
nostic equipment, however, is one of the limiting factors for an 
efficient management of this disease; the only reliable and 
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endorsed technology has, nonetheless, been 
restricted to a few large hospitals. Axial dual-
energy photon X-ray absorptiometry (DEXA) 
equipment is expensive, non-portable, requir-
ing specialized training and is usually restricted 
to secondary-care hospitals. Given the consid-
erable health problems posed by postmeno-
pausal osteoporosis, a need is felt for low-cost 
diagnostic methods for identifying women at 
risk of having fragility fractures. Dual X-ray and 
laser (DXL) applied to the heel bone is a rela-
tively inexpensive portable technique which 
may be used in ambulatory settings as well as 
at orthopaedic wards and osteoporosis clinics. 
Previous studies have shown that BMD meas-
ured by the DXL Calscan (Demetech AB, 
Sweden) device was in concord with the WHO 
criteria and in good agreement with measure-
ments read at the femoral neck and spine.7 
The objective of the present study was to de-
termine the ability of DXL in measurement of 
the calcaneus BMD in an Iranian female popu-
lation as compared with DEXA. 
 
Patients and Methods 
 
The measurement of BMD in the non-dominant 
calcaneus bone by DXL was made in 475 fe-
male patients with the mean age 54±11.9 yrs, 
body weight 69.312.4 kg, height 154.2±6.3 cm, 
BMI 29.2±5.2 kg/m2, PA spine BMD 
1.031±0.218 g/cm2, total hip BMD 0.871±0.147 
g/cm2, and calcaneus BMD 0.368±0.085 g/cm2. 
The participants were routinely referred for as-
sessment of BMD. The BMD in these patients 
was also measured in their spine (L2–L4) in an-
terior-posterior projection, the femoral neck and 
their hip by DEXA using a Lunar DPX MX den-
sitometer (Madison, USA). The patients were 
positioned for the scanning according to the 
manufacturer’s instructions. 
The data on reference sample for the axial de-
vice, used in our patients, was that of NHANES 
III population.  For the heel device, the refer-
ence sample data was from a North European 
origin,8 provided by the manufacturer. Each 
subject was categorized as being normal if she 
had a T-score ≥-1.0; osteopenic if -2.5<T-
score<-1.0; or osteoporotic if T-score≤-2.5.9  For 
the axial DEXA the lowest T-score value read in 
femoral neck or lumbar spine was used for the 
diagnostic categorization. 
 
Results 
 
Of the studied group, 70 (15%) had osteoporo-
sis, 185 (39%) had osteopenia and 220 (46%) 
were healthy, according to the axial bone den-
sitometry using DEXA.  The Pearson correla-
tion coefficient between T-score values esti-
mated at different measurement sites are pre-
sented in Table 1. 
The sensitivity and specificity for DXL in diag-
nosing osteoporosis and osteopenia as com-
pared with that diagnosed by DEXA, were cal-
culated (Table 2). We had excellent sensitivity 
and specificity for the diagnosis of osteoporosis. 
A cut-off T-score of ≤-2.5 for DXL Calscan iden-
tifies about the same number of patients as os-
teoporotic as do measurements of DEXA. How-
ever, in our study, the high sensitivity for the 
diagnosis of osteopenia is not followed by a 
high specificity for the diagnosis of osteopenia. 
Recalculation of the sensitivity and specificity 
using a different cut-off value for osteopenia (-
2.5<T-score<-1.5) yields a sensitivity of 83% 
and a specificity of 74% for osteopenia (Table 
3). The Kappa statistic of 0.61 denotes a good 
agreement between the measurements made 
by DXL Calscan and DEXA for the diagnosis of 
osteoporosis. 
 
Discussion 
 
Vitamin D deficiency which affects bone min-
eral metabolism, is reported in Iranian 
women.10,11 The low calcium intake in the re-
gion influences the skeletal health. However, 
the importance of timely diagnosis, accessibil-
ity of measurement devices and the cost of 
measurements are limiting factors for finding 
the patients at risk. This study, which is con-
firmed by many recent reports,12,13 showed that 
diagnosis and evaluation of osteoporosis could 
be established with limited resources, say a 
DXL device. 
The DXL technique uses two X-ray ener-
gies in combination with laser measurement of 
the object thickness in order to determine three 
tissue components with a high accuracy. Since 
the total thickness of the object being meas-
ured is composed of the individual thicknesses 
Table 1: Correlation of T-score values at different meas-
urement sites (Pearson coefficient of correlation). All 
correlations were highly significant (p<0.001).  
 DXL Calscan
Lumbar 
Spine 
Femoral 
Neck 
DXL Calscan – 0.68 0.71 
Lumbar Spine 0.68 – 0.65 
Femoral Neck 0.71 0.65 – 
Total Hip 0.73 0.62 0.90 
Table 2: Sensitivity and specificity (%), for diagnosis of 
osteoporosis and osteopenia (values in parenthesis are 
for the T-score threshold <-1.5). 
 Osteoporosis 
 (T-score <-2.5) 
Osteopenia 
(-2,5<T-score<-1.0) 
Sensitivity % 83 96 
Specificity% 86 (86) 42 (74) 
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of bone mineral, lean soft tissue and fat, it is 
possible to combine the thickness measure-
ment with the two X-ray measurements and 
obtain a unique solution of the three different 
components of the measurement site. 
An axial DEXA device can normally meas-
ure the BMD in 15–20 persons a day. The pe-
ripheral device used in this study is much 
cheaper and can normally handle about 70 to 
80 patients a day. This device is mobile, and 
requires no trained personnel. 
 This study showed a high correlation be-
tween the DXL Calscan and axial DEXA 
measurements. We also found that the WHO 
criteria could be used with a high sensitivity 
and specificity with present reference data. 
However, the cut-off value for diagnosis of os-
teopenia should be modified to a T-score be-
tween -1.5 and -2.5, if complete agreement with 
the WHO definition using DEXA, is the goal. 
The somewhat higher cut-off value for os-
teopenia by DXL Calscan device found in this 
study as compared to the WHO criteria may be 
due to the large amount of trabecular bone in 
the heel bone. Calcaneus is weight-bearing 
and composed of more than 90% trabecular 
bone. The proximal femur consists of about 
43%,14 and lumbar spine about 42% trabecular 
bone.15  The turnover rate of trabecular bone is 
6–8 times faster than cortical bone. The trabe-
cular bone has a higher remodeling rate than 
cortical bone and the heel bone density may 
therefore be measured for early diagnosis of 
osteoporosis. The calcaneus bone has been 
shown to predict the relative risk of all fractures 
in the hip and lumbar spine. For the prediction 
of vertebral fracture, calcaneus mineral density 
(BMD) measurements are similar to those of 
the spine and better than values for the fore-
arm and hip.16  
One limitation of our study was that it referred 
to a population in Teheran, and its external 
validity needs, therefore, to be confirmed. Our 
patients selection were not without bias; inclu-
sion of those women attending the osteoporosis 
clinic could represent a bias towards cases with 
higher incidence of the disease. However, given 
that these were the real life conditions in the 
everyday practice in an osteoporosis clinic, this 
factor might improve the validity of our results.  
In light of the high prevalence of osteoporosis 
in the population and its severe complications, 
a peripheral measurement technique may 
have great potential in lessening the burden of 
osteoporosis for the society and the patients. 
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